(Q34305448)

1 August 2017

1 reference

title

Cerebral blood flow and metabolic abnormalities in Alzheimer's disease (English)

1 reference

1 August 2017

0 references

0 references

Matsuda H

1

1 reference

1 August 2017

1 April 2001

1 reference

Annals of Nuclear Medicine

1 August 2017

1 reference

1 August 2017

15

1 reference

1 August 2017

85-92

1 reference

1 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02988596

1 August 2017

0 references

cites work

Alzheimer's disease: focal cortical changes shown by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Imaging local brain function with emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Positron emission tomography in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

NIH Conference. Brain imaging: aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Cognitive deficits and clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Preclinical prediction of Alzheimer's disease using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

A PROPOSED MECHANISM OF EMOTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Visual attention impairments in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

Orbital and Dorsolateral Frontal Perfusion Defect Associated With Behavioral Response to Cholinesterase Inhibitor Therapy in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02988596

21 January 2018

Identifiers

DOI

10.1007/BF02988596

1 reference

PubMed ID

11448080

Dimensions Publication ID

1 August 2017

1047696517

0 references

Fatcat ID

release_texnviy6cvelffpby5poyfshue

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/texnviy6cvelffpby5poyfshue

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

11448080

1 reference

PubMed ID

11448080